Metro Healthcare Indonesia
PT Metro Healthcare Indonesia Tbk owns, operates, and manages hospitals in Indonesia. It provides the management of hospitals, clinics, treatment hall, polyclinics, and other medical centers; physical medicine and trading; industry, development, and services; professional, scientific, technical, financial, and investment services; transportation, workshop, forestry, and agriculture services; heal… Read more
Metro Healthcare Indonesia (CARE) - Total Liabilities
Latest total liabilities as of September 2025: Rp1.17 Trillion IDR
Based on the latest financial reports, Metro Healthcare Indonesia (CARE) has total liabilities worth Rp1.17 Trillion IDR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Metro Healthcare Indonesia - Total Liabilities Trend (2016–2024)
This chart illustrates how Metro Healthcare Indonesia's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Metro Healthcare Indonesia Competitors by Total Liabilities
The table below lists competitors of Metro Healthcare Indonesia ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Luoxin Pharmaceuticals Group Stock Co Ltd
SHE:002793
|
China | CN¥2.46 Billion |
|
Raydium Semi-Conductor
TW:3592
|
Taiwan | NT$7.71 Billion |
|
Henan Taloph Pharmaceutical Stock Co Ltd
SHG:600222
|
China | CN¥2.09 Billion |
|
Mesabi Trust
NYSE:MSB
|
USA | $4.91 Million |
|
Harbin Xinguang Optic Electronics
SHG:688011
|
China | CN¥156.89 Million |
|
ZimVie Inc
NASDAQ:ZIMV
|
USA | $345.42 Million |
|
QuantumScape Corporation
SA:Q2SC34
|
Brazil | R$139.18 Million |
|
ZheJiang RIFA Digital Precision Machinery Co Ltd
SHE:002520
|
China | CN¥2.24 Billion |
Liability Composition Analysis (2016–2024)
This chart breaks down Metro Healthcare Indonesia's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.30 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.48 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Metro Healthcare Indonesia's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Metro Healthcare Indonesia (2016–2024)
The table below shows the annual total liabilities of Metro Healthcare Indonesia from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Rp1.00 Trillion | -3.52% |
| 2023-12-31 | Rp1.04 Trillion | +1.12% |
| 2022-12-31 | Rp1.03 Trillion | +12.57% |
| 2021-12-31 | Rp912.94 Billion | +489.32% |
| 2020-12-31 | Rp154.91 Billion | -11.64% |
| 2019-12-31 | Rp175.33 Billion | -69.73% |
| 2018-12-31 | Rp579.15 Billion | +82.88% |
| 2017-12-31 | Rp316.69 Billion | +50.20% |
| 2016-12-31 | Rp210.85 Billion | -- |